Ledger.Open graph →
SEC Form D · filed June 6, 2018

Sound Pharmaceuticals Inc

Offering
$10.4M
Sold
$8.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

James C. Towne · Seattle, WADirectorDavid Guyer · Mt. Arlington, NJDirectorJonathan Kil · Seattle, WAExec · DirectorJoseph Ashley · Seattle, WADirectorJohn C. Sullivan · Cambridge, MAExecGlenn Kawasaki · Seattle, WADirectorDavid Guyer · Seattle, WADirectorJames C. Towne · Kirkland, WADirectorJonathan Kil · Seattle, WAExec · DirectorJoseph Ashley · Seattle, WADirectorJohn C. Sullivan · Cambridge, MAExecGlenn Kawasaki · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗